ABL BIOTEC A/S: Financial statements 2017
CVR: 50811018
Source: annual report 2017, Danish Business Authority
01/01/2017 – 31/12/2017
ABL BIOTEC A/S (CVR 50811018) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK -125,116 and a net result of DKK 1,139,039 compared with DKK 795,892 the year before. Equity in the 2017 report amounted to DKK 24,577,622. The solvency ratio was 98.8%. The company had 1 employee in the financial year.
- Gross Profit
- DKK -125,116
- Profit/Loss
- DKK 1,139,039
- Equity
- DKK 24,577,622
- Total Assets
- DKK 24,864,880
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | - | -125 t. | 1.1 mio. | 24.6 mio. | 1 |
| 2016 | - | -118 t. | 796 t. | 24.5 mio. | 1 |
| 2015 | - | -122 t. | 2.2 mio. | 24.8 mio. | - |
| 2014 | - | -100 t. | 3.8 mio. | 23.7 mio. | - |
| 2013 | - | -97 t. | 2.7 mio. | 22.4 mio. | - |
Official annual report
Keep an eye on ABL BIOTEC A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
ABL BIOTEC A/S has published its annual report for 2016. Gross profit came to DKK -117,780, and the net result was DKK 795,892.
About ABL BIOTEC A/S
ABL BIOTEC A/S is a Danish company of the type Aktieselskab based in Højbjerg, founded in 1974. The company is registered under the industry Anden finansiel formidling i.a.n.. The management consists of Asger Bach-Larsen. The board consists of Kirsten Bach-Larsen (chair), Gitte Larsen and Rikke Dahl Andersson. The company is owned by Asger Bach-Larsen and Kirsten Bach-Larsen. The company has 0 employees (2018). In 2025, the company reported a gross profit of DKK -129,949 and a net result of DKK -116,723 compared with DKK 3,704,421 the year before. Equity in the 2025 report amounted to DKK 27,884,586.